重复神经刺激在肌萎缩侧索硬化和重症肌无力患者的应用比较 Application of Repetitive Nerve Stimulation in Patients with Amyotrophic Lateral Sclerosis and Myasthenia Gravis:A Comparative Study
Appel SH,Smith RG,Engelhardt JI,et al.Evidence for autoimmunity in amyotrophic lateral sclerosis[J].J Neurol Sci,1993,118(2):169-174.
[2]
Mori A,Yamashita S,Nakajima M,et al.CMAP decrement as a potential diagnostic marker for ALS[J].Acta Neurol Scand,2015Oct 4.[Epub ahead of print]
[3]
Jing F,Cui F,Chen Z,et al.Clinical and electrophysiological markers in myasthenia gravis patients[J].Eur Neurol,2015,74(1-2):22-27.
[4]
Mehanna R,Patton EL Jr,Phan CL,et al.Amyotrophic lateral sclerosis with positive anti-acetylcholine receptor antibodies.Case report and review of the literature[J].J Clin Neuromuscul Dis,2012,14(2):82-85.
[5]
de Carvalho M,Swash M.Nerve conduction studies in amyotrophic lateral sclerosis[J].Muscle Nerve,2000,23(3):344-352.
[6]
Cheah BC,Vucic S,Krishnan AV.Neurophysiological index as a biomarker for ALS progression:validity of mixed effects models[J].Amyotroph Lateral Scler,2011,12(1):33-38.
[7]
Killian JM,Wilfong AA,Burnett L.Decremental motor responses to repetitive nerve stimulation in ALS[J].Muscle Nerve,1994,17(7):747-754.
[8]
Wang FC,De Pasqua V,Gérard P,et al.Prognostic value of decremental responses to repetitive nerve stimulation in ALS patients[J].Neurology,2001,57(5):897-899.
Yamashita S,Sakaguchi H,Mori A,et al.Significant CMAP decrement by repetitive nerve stimulation is more frequent in median than ulnar nerves of patients with amyotrophic lateral sclerosis[J].Muscle Nerve,2012,45(3):426-428.
[11]
Cedarbaum JM,Stambler N,Malta E,et al.The ALSFRS-R:a revised ALS functional rating scale that incorporates assessments of respiratory function.BDNF ALS Study Group(PhaseⅢ)[J].J Neurol Sci,1999,169(1-2):13-21.
[12]
Brooks BR.El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis.Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial"Clinical limits of amyotrophic lateral sclerosis"workshop contributors[J].J Neurol Sci,1994,124(Suppl):S96-S107.
[13]
Joyce NC,Carter GT.Electrodiagnosis in persons with amyotrophic lateral sclerosis[J].PMR,2013,5(Suppl):S89-S95.
[14]
Iwanami T,Sonoo M,Hatanaka Y,et al.Decremental responses to repetitive nerve stimulation(RNS)in motor neuron disease[J].Clin Neurophysiol,2011;122(12):2 530-2 536.
[15]
Schepelmann K,Winter Y,Spottke AE,et al.Socioeconomic burden of amyotrophic lateral sclerosis,myasthenia gravis and facioscapulohumeral muscular dystrophy[J].J Neurol,2010,257(1):15-23.
[16]
Brooks BR,Miller RG,Swash M,et al.World Federation of Neurology Research Group on Motor Neuron Diseases.El Escorial revisited:revised criteria for the diagnosis of amyotrophic lateral sclerosis[J].Amyotroph Lateral Scler Other Motor Neuron Disord,2000,1(5):293-299.
[17]
American Association of Electrodiagnostic Medicine.Guidelines in electrodiagnostic medicine[J].Muscle Nerve,1992,5(2):229-253.
[18]
Edds MV Jr.Hypertrophy of nerve fibers to functionally overloaded muscles[J].J Comp Neurol,1950,93(2):259-275.
[19]
贾建平,陈生弟,崔丽英,等.神经病学[M].第7版,北京:人民卫生出版社,2013.
[20]
Meriggioli MN,Sanders DB.Autoimmune myasthenia gravis:emerging clinical and biological heterogeneity[J].Lancet Neurol,2009,8(5):475-490.
[21]
Traynor BJ,Zhang H,Shefner JM,et al.Functional outcome measures as clinical trial endpoints in ALS[J].Neurology,2004,63(10):1 933-1 935.
de Carvalho M,Dengler R,Eisen A,et al.Electrodiagnostic criteria for diagnosis of ALS[J].Clin Neurophysiol,2008,119(3):497-503.
[25]
AAEM Quality Assurance Committee.American Association of Electrodiagnostic Medicine.Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome:summary statement[J].Muscle Nerve,2001,24(9):1 236-1 238.
[26]
Mulder DW,Lambert EH,Eaton LM.Myasthenic syndrome in patients with amyotrophic lateral sclerosis[J].Neurology,1959,9(10):627-631.
[27]
Denys EH,Norris FH Jr.Amyotrophic lateral sclerosis.Impairment of neuromuscular transmission[J].Arch Neurol,1979,36(4):202-205.
[28]
Ruff RL.Endplate contributions to the safety factor for neuromuscular transmission[J].Muscle Nerve,2011,44(6):854-861.
